TASLY PHARMACEUTICAL GROUP CO.,LTD
Research TASLY PHARMACEUTICAL GROUP CO.,LTD (600535.SS) on Bullrun: market cap CNY 20.89B, P/E 17.0, dividend yield 2.4%. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- Ticker600535.SS
- ExchangeSS
- CountryChina
- SectorHealthcare
- IndustryDrug Manufacturers - Specialty & Generic
- CurrencyCNY
- Market capCNY 20.89B
- P/E17.0
- Dividend yield2.4%
- Financial periodQ2 2026
- RevenueCNY 2.04B
- Net incomeCNY 522.44M
- Free cash flowCNY 626.58M
- Gross margin67.8%
Valuation Snapshot
latest market cap is CNY 20.89B; P/E is 17.0; dividend yield is 2.4%.
Peer valuation comparison
Latest P/E is 17.05x versus a Healthcare sector median of 21.8x (21.8% below).
Latest dividend yield is 2.43% versus a Healthcare sector median of 2.4%.
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-11-11 | CNY 20.89B | 17.0 | 2.4% | 0.34 |
Dividend history
Latest trailing dividend snapshot: annual dividend/share 0.34 CNY, yield 2.4%.
About TASLY PHARMACEUTICAL GROUP CO.,LTD
Tasly Pharmaceutical Group Co., Ltd, together with its subsidiaries, engages in the research, development, production, and sale of pharmaceuticals in China. The company offers prescription drugs covering various therapeutic areas, including cardiovascular-cerebrovascular, tumor immunity, digestion and metabolism, and neuroscience; over-the-counter drugs; modern TCM; biological drugs; and chemical drugs. It also engages in medical instruments, agriculture, and chain drugstore activities.
ETFs that hold TASLY PHARMACEUTICAL GROUP CO.,LTD
US-listed ETFs
TASLY PHARMACEUTICAL GROUP CO.,LTD is held by 19 US-listed ETFs, going by the latest portfolios they filed with the SEC. The 8 most traded of them:
| ETF | Weight | Fee |
|---|---|---|
| Vanguard Total International Stock Index Fund ETF Shares (VXUS) | <0.01% | 0.05% |
| Vanguard FTSE Emerging Markets Index Fund ETF Shares (VWO) | <0.01% | 0.06% |
| Vanguard Total World Stock Index Fund ETF Shares (VT) | <0.01% | 0.06% |
| Vanguard FTSE All-World ex-US Index Fund ETF Shares (VEU) | <0.01% | 0.04% |
| Schwab Emerging Markets Equity ETF (SCHE) | <0.01% | 0.06% |
| Vanguard International High Dividend Yield Index Fund ETF Shares (VYMI) | <0.01% | 0.07% |
| Dimensional Emerging Core Equity Market ETF (DFAE) | <0.01% | 0.29% |
| Dimensional Emerging Markets Core Equity 2 ETF (DFEM) | <0.01% | 0.39% |
Portfolios as filed with the SEC on Form N-PORT, dated May to July 2026. Brokers in the EU generally do not offer US-listed ETFs to retail investors.
Related stock research
Other Healthcare stocks
Frequently asked questions
What is TASLY PHARMACEUTICAL GROUP CO.,LTD's market cap?
TASLY PHARMACEUTICAL GROUP CO.,LTD's market capitalization is CNY 20.89B.
What is TASLY PHARMACEUTICAL GROUP CO.,LTD's P/E ratio?
TASLY PHARMACEUTICAL GROUP CO.,LTD's price-to-earnings (P/E) ratio is 17.0.
Does TASLY PHARMACEUTICAL GROUP CO.,LTD pay a dividend?
TASLY PHARMACEUTICAL GROUP CO.,LTD has a dividend yield of 2.4%.
What does TASLY PHARMACEUTICAL GROUP CO.,LTD do?
Tasly Pharmaceutical Group Co., Ltd, together with its subsidiaries, engages in the research, development, production, and sale of pharmaceuticals in China. The company offers prescription drugs covering various therapeutic areas, including cardiovascular-cerebrovascular, tumor immunity, digestion and metabolism, and neuroscience; over-the-counter drugs; modern TCM; biological drugs; and chemical drugs. It also engages in medical instruments, agriculture, and chain drugstore activities. The company was formerly known as Tianjin Tasly Pharmaceutical Co., Ltd.